At the same time, miR-132 showed neuroprotective effects by influencing ERK/MAPK1 activity, with the consequent reduction of both Aβ and Tau pathology hallmarks, as well as oxidative stress in AD animal models. This evidence concerns the gene MAPT and Alzheimer disease.